Loading...
XSHG
603233
Market cap2.67bUSD
Jul 09, Last price  
16.95CNY
1D
-0.76%
1Q
-1.63%
IPO
16.68%
Name

DaShenLin Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
P/E
16.45
P/S
0.78
EPS
1.03
Div Yield, %
1.83%
Shrs. gr., 5y
0.94%
Rev. gr., 5y
22.59%
Revenues
24.53b
+15.45%
3,252,460,2263,706,656,0744,545,011,0075,265,481,8596,273,722,0227,421,196,9038,859,273,70811,141,165,08214,582,865,28216,759,335,26421,248,086,69224,531,390,152
Net income
1.17b
+12.63%
149,183,213197,382,181265,501,554395,434,058430,188,669474,960,964531,633,897702,661,9611,062,181,101791,230,9801,035,723,8341,166,498,182
CFO
3.17b
-15.51%
289,310,273288,219,956448,578,297468,587,221495,601,186640,388,127873,639,8441,707,770,7071,953,915,8281,554,994,8633,756,573,4353,173,848,332
Dividend
Jun 21, 20240.31 CNY/sh

Profile

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
URL
http://www.dslyy.com/
IPO date
Jul 31, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
24,531,390
15.45%
21,248,087
26.78%
Cost of revenue
21,762,645
18,760,207
Unusual Expense (Income)
NOPBT
2,768,745
2,487,880
NOPBT Margin
11.29%
11.71%
Operating Taxes
397,124
335,621
Tax Rate
14.34%
13.49%
NOPAT
2,371,621
2,152,259
Net income
1,166,498
12.63%
1,035,724
30.90%
Dividends
(569,451)
(395,465)
Dividend yield
2.02%
1.05%
Proceeds from repurchase of equity
(946)
BB yield
0.00%
Debt
Debt current
759,733
1,679,616
Long-term debt
7,777,698
7,041,594
Deferred revenue
17,642
Other long-term liabilities
28,967
328
Net debt
3,923,510
4,095,998
Cash flow
Cash from operating activities
3,173,848
3,756,573
CAPEX
(1,796,641)
Cash from investing activities
(1,986,828)
Cash from financing activities
(1,968,637)
FCF
1,123,651
1,710,991
Balance
Cash
4,458,334
4,585,039
Long term investments
155,587
40,172
Excess cash
3,387,352
3,562,807
Stockholders' equity
5,931,918
5,488,909
Invested Capital
10,042,122
9,006,276
ROIC
24.90%
25.75%
ROCE
20.62%
19.79%
EV
Common stock shares outstanding
1,132,523
1,136,103
Price
24.90
-24.55%
33.00
12.85%
Market cap
28,199,810
-24.78%
37,491,413
12.90%
EV
33,232,552
42,239,681
EBITDA
4,464,636
3,775,997
EV/EBITDA
7.44
11.19
Interest
275,338
48,235
Interest/NOPBT
9.94%
1.94%